Literature DB >> 11071802

Stents in total occlusion for restenosis prevention. The multicentre randomized STOP study. The Israeli Working Group for Interventional Cardiology.

C Lotan1, Y Rozenman, A Hendler, Y Turgeman, O Ayzenberg, R Beyar, R Krakover, T Rosenfeld, M S Gotsman.   

Abstract

AIMS: This multicentre randomized study set out to evaluate whether coronary stenting improves the results of successful balloon angioplasty for chronic total occlusion. Balloon angioplasty for chronic total occlusion has a high restenosis rate. Several reports have suggested that coronary stenting may decrease the likelihood of restenosis and reocclusion. METHODS AND
RESULTS: Patients with total coronary artery occlusions who had an optimal PTCA result were randomized either to no further treatment or additional stent implantation. The AVE microstent was used and all patients were scheduled for a 1-, 3-, and 6-month clinical follow-up. Repeat coronary angiography to assess the rate and pattern of restenosis was performed at 6 months or earlier if clinically indicated. Ninety-six patients were enrolled in this study. The mean age was 59. 3+/-10.3 years and 15 were females. Forty-eight patients were randomized to the stent arm, receiving 52 stents (lengths 18-39 mm). Stent implantation was successful in all and there were no major procedure-related complications. Sixty-nine patients (72%) were restudied after 6 months. The binary restenosis rates (50%), in the PTCA arm were 70.9% with a minimal lumen diameter of 1.01+/-0.79 mm compared to 42.1% in the stent arm with a minimal lumen diameter of 1.63+/-1.02 mm (P=0.034). Reocclusion occurred in 7.9% in the stent group compared to 16.1% in the PTCA group. Restenosis in the PTCA group was focal in 88% of patients and occurred at the point of total obstruction (within 5 mm), compared to diffuse instent restenosis, which occurred in 54% of the patients in the stent group.
CONCLUSION: Coronary stenting can significantly decrease the rate of restenosis and reocclusion of total occlusions. As restenosis in the stent group was more diffuse, care should be taken to implant short stents at the site of occlusion. Copyright 2000 The European Society of Cardiology.

Entities:  

Mesh:

Year:  2000        PMID: 11071802     DOI: 10.1053/euhj.2000.2295

Source DB:  PubMed          Journal:  Eur Heart J        ISSN: 0195-668X            Impact factor:   29.983


  6 in total

Review 1.  Chronic total occlusions--a stiff challenge requiring a major breakthrough: is there light at the end of the tunnel?

Authors:  S Aziz; D R Ramsdale
Journal:  Heart       Date:  2005-06       Impact factor: 5.994

2.  Utility of drug-eluting stents in complex lesions and high-risk patients.

Authors:  Eugenia Nikolsky; Gregg W Stone
Journal:  Curr Treat Options Cardiovasc Med       Date:  2007-02

3.  Are "treatment" bare metal stents superior to "control" bare metal stents? A meta-analytic approach.

Authors:  David M Kent; Thomas A Trikalinos
Journal:  Am Heart J       Date:  2008-01-18       Impact factor: 4.749

4.  Sirolimus-eluting stents in the treatment of chronic total coronary occlusions: results from the prospective multi-center German Cypher Stent Registry.

Authors:  Christian Zellerhoff; Steffen Schneider; Jochen Senges; Thomas Pfannebecker; Christian Hamm; Ulrich Tebbe
Journal:  Clin Res Cardiol       Date:  2007-11-28       Impact factor: 5.460

5.  Antegrade Techniques for Chronic Total Occlusions

Authors:  Michael Cl Lim
Journal:  Curr Cardiol Rev       Date:  2015-11-06

Review 6.  The evidence base for revascularisation of chronic total occlusions.

Authors:  Alan Bagnall; Ioakim Spyridopoulos
Journal:  Curr Cardiol Rev       Date:  2014-05
  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.